Skip to main content

Sharing images of patients electronically

In a recent article in a medical magazine, I and two other commentators discuss issues around the electronic sharing of images of patients that clinicans should be aware of.

The very high use of information technology in modern society has resulted in the practical uses of sending and sharing information electronically rapidly outstripping published guidance in this area. For example, many NHS organisations have draconian policies about sending patient information by email – in some cases describing sending information by unencrypted email as similar to ‘sending it on a postcard’. No empirical evidence is ever presented in such guidance that sending information electronically is any less secure than sending it by post or telephone. Guidance from such organisations has also yet to catch up with the now near-ubiquitous access to smartphones, high-speed Internet connections and high-resolution cameras in our society. In my opinion, it is acceptable for the photo to be stored on your phone as long as you take reasonable precautions to secure your device.

Most patients would generally be happy to have an image of their skin condition shared with your colleague if this helped in getting a better diagnosis or a more appropriate treatment plan. You should though obtain consent from the patient before sharing the image with your colleague. If you are apprehensive about using a photo or file sharing app, you could send the image from one NHS Net email account to another. NHS email is a fully encrypted method of communication and can be used for sending sensitive patient information. If you want to use the image in a presentation, then you should get explicit consent for this from the patient, ideally in writing, as is now standard for case reports in medical journals.

We should encourage the use of technology as a tool for improving quality of care, patient experience and health outcomes; but at the same time, we must ensure that we respect patient confidentiality and always obtain informed consent from patients before sharing their information electronically.

You can read the full article in Pulse.

Comments

Popular posts from this blog

What is the difference between primordial prevention and primary prevention?

Primordial prevention and primary prevention are both crucial strategies for promoting health, but they operate at different levels. Primordial prevention aims to address the root causes of health problems and improve the wider determinants of health. It focuses on preventing the emergence of risk factors in the first place by tackling the underlying social, economic, and environmental determinants of health. This involves broad, population-wide interventions such as: Policies that promote healthy food choices: Think about initiatives like taxing sugary drinks to discourage unhealthy consumption, or providing subsidies for fruits and vegetables to make them more accessible. Urban planning that prioritises well-being: This could include creating walkable neighborhoods with safe cycling routes, ensuring access to green spaces for recreation and relaxation, and designing communities that foster social connections. Social programs that address inequality: Initiatives aimed at reducing pov...

Talking to Patients About Weight-Loss Drugs

The use of weight-loss drugs such as GLP-1 receptor agonists (e.g., semaglutide, tirzepatide) has increased rapidly in recent years. These drugs can help some people achieve significant weight reduction, but they are not suitable for everyone and require careful counselling before starting treatment. By discussing benefits, risks, practicalities, and  uncertainties, clinicians can help patients make informed, realistic decisions about their treatment. Key points to discuss with patients 1. Indications and eligibility These drugs are usually licensed for adults with a specific BMI. They should be used alongside lifestyle interventions such as dietary change, increased physical activity, and behaviour modification. 2. Potential side effects – some can be serious Common adverse effects include nausea, vomiting, diarrhoea, and abdominal discomfort. Less common but more serious risks include gallstones, pancreatitis and visual problems. Patients should know what to watch for a...

What makes a good doctor – and who gets to decide?

What Makes a Good Doctor? This is the question that Waseem Jerjes and I explore in the Journal of the Royal Society of Medicine . It is a key question that underpins the architecture of medical education, clinical practice, regulation, and professional identity. It cannot be answered by regulators, educators, or employers in isolation. It must be answered together – by doctors and patients – revisited throughout a career, and adapted as society and the profession change. Without that shared reflection, the danger is not simply disillusionment, but the erosion of the moral foundations of clinical work. As we enter an era when diagnosis will increasingly involve artificial intelligence and when performance metrics reward volume over value, reclaiming this question as a professional one is imperative. The integrity of our institutions – and of the practitioners within them – depends on reimagining excellence in inclusive, relational terms. A good doctor is not a flawless technician or a f...